Simpler Grants.gov #HT942526TSCRPEHDA

Tuberous Sclerosis Complex Research Program Exploration-Hypothesis Development Award (FY26)

This opportunity from the Dept. of the Army (USAMRAA) invites applications for the FY26 Tuberous Sclerosis Complex Research Program Exploration-Hypothesis Development Award. - Government Buyer: - U.S. Army Medical Research Acquisition Activity (USAMRAA) - Congressionally Directed Medical Research Programs (CDMRP) - Program Details: - Supports innovative, high-risk, high-gain research in tuberous sclerosis complex (TSC) - No preliminary data required; applicants must demonstrate ability to achieve interpretable results without such data - Approximately six awards anticipated - Total program budget: $2.1 million - Maximum award: $350,000 per recipient - Period of performance: up to two years per award - Notable Requirements: - Unrestricted eligibility for applicants - No cost-sharing or matching requirement - No OEMs, vendors, or commercial products/services are specified, as this is a research grant opportunity - Place of performance and contracting office: USAMRAA (Dept. of the Army)

Description

The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain and potentially groundbreaking concepts in the tuberous sclerosis complex (TSC) research field. Preliminary data is not required, and applications should demonstrate the ability to achieve interpretable results without preliminary data supporting the hypothesis. The program expects to allot roughly $2.1 million to fund approximately six awards, each with a total cost cap of $350,000 and a maximum period of performance of 2 years. Awards will be funded with FY26 funds, which will expire for use on September 30, 2032, and awards will be made no later than September 30, 2027.

View original listing